These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37002296)

  • 1. A clinical decision support system for AI-assisted decision-making in response-adaptive radiotherapy (ARCliDS).
    Niraula D; Sun W; Jin J; Dinov ID; Cuneo K; Jamaluddin J; Matuszak MM; Luo Y; Lawrence TS; Jolly S; Ten Haken RK; El Naqa I
    Sci Rep; 2023 Mar; 13(1):5279. PubMed ID: 37002296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantum deep reinforcement learning for clinical decision support in oncology: application to adaptive radiotherapy.
    Niraula D; Jamaluddin J; Matuszak MM; Haken RKT; Naqa IE
    Sci Rep; 2021 Dec; 11(1):23545. PubMed ID: 34876609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep reinforcement learning for automated radiation adaptation in lung cancer.
    Tseng HH; Luo Y; Cui S; Chien JT; Ten Haken RK; Naqa IE
    Med Phys; 2017 Dec; 44(12):6690-6705. PubMed ID: 29034482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision radiotherapy via information integration of expert human knowledge and AI recommendation to optimize clinical decision making.
    Sun W; Niraula D; El Naqa I; Ten Haken RK; Dinov ID; Cuneo K; Jin JJ
    Comput Methods Programs Biomed; 2022 Jun; 221():106927. PubMed ID: 35675722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calculating the individualized fraction regime in stereotactic body radiotherapy for non-small cell lung cancer based on uncomplicated tumor control probability function.
    Lu JY; Lin PX; Huang BT
    Radiat Oncol; 2019 Jun; 14(1):111. PubMed ID: 31221159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An artificial intelligence-driven agent for real-time head-and-neck IMRT plan generation using conditional generative adversarial network (cGAN).
    Li X; Wang C; Sheng Y; Zhang J; Wang W; Yin FF; Wu Q; Wu QJ; Ge Y
    Med Phys; 2021 Jun; 48(6):2714-2723. PubMed ID: 33577108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized mid-course FDG-PET based adaptive treatment planning for non-small cell lung cancer using machine learning and optimization.
    Ajdari A; Liao Z; Mohan R; Wei X; Bortfeld T
    Phys Med Biol; 2022 Sep; 67(18):. PubMed ID: 35947984
    [No Abstract]   [Full Text] [Related]  

  • 8. Approach and assessment of automated stereotactic radiotherapy planning for early stage non-small-cell lung cancer.
    Bai X; Shan G; Chen M; Wang B
    Biomed Eng Online; 2019 Oct; 18(1):101. PubMed ID: 31619263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining handcrafted features with latent variables in machine learning for prediction of radiation-induced lung damage.
    Cui S; Luo Y; Tseng HH; Ten Haken RK; El Naqa I
    Med Phys; 2019 May; 46(5):2497-2511. PubMed ID: 30891794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer.
    Xiao L; Liu N; Zhang G; Zhang H; Gao S; Fu Z; Wang S; Yu Q; Yu J; Yuan S
    PLoS One; 2017; 12(1):e0170901. PubMed ID: 28125698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation.
    Nieder C; De Ruysscher D; Gaspar LE; Guckenberger M; Mehta MP; Cheung P; Sahgal A
    Strahlenther Onkol; 2017 Jul; 193(7):515-524. PubMed ID: 28424839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial intelligence to predict outcomes of head and neck radiotherapy.
    Bang C; Bernard G; Le WT; Lalonde A; Kadoury S; Bahig H
    Clin Transl Radiat Oncol; 2023 Mar; 39():100590. PubMed ID: 36935854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival benefits for non-small cell lung cancer patients treated with adaptive radiotherapy.
    Møller DS; Lutz CM; Khalil AA; Alber M; Holt MI; Kandi M; Schmidt HH; Tvilum M; Appelt A; Knap MM; Hoffmann L
    Radiother Oncol; 2022 Mar; 168():234-240. PubMed ID: 35121030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric Planning Tradeoffs to Reduce Heart Dose Using Machine Learning-Guided Decision Support Software in Patients with Lung Cancer.
    Bitterman DS; Selesnick P; Bredfeldt J; Williams CL; Guthier C; Huynh E; Kozono DE; Lewis JH; Cormack RA; Carpenter CM; Mak RH; Atkins KM
    Int J Radiat Oncol Biol Phys; 2022 Mar; 112(4):996-1003. PubMed ID: 34774998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study.
    Su TS; Liu QH; Zhu XF; Liang P; Liang SX; Lai L; Zhou Y; Huang Y; Cheng T; Li LQ
    Radiat Oncol; 2021 Apr; 16(1):79. PubMed ID: 33882972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should stereotactic body radiotherapy doses be adjusted according to tumor size in early-stage non-small-cell lung cancer? A systematic review and meta-analysis.
    Luo H; Cui Y; Song H; Mao R; Gao Q; Ge H
    Future Oncol; 2019 Sep; 15(26):3071-3079. PubMed ID: 31426674
    [No Abstract]   [Full Text] [Related]  

  • 17. A reinforcement learning approach for finding optimal policy of adaptive radiation therapy considering uncertain tumor biological response.
    Ebrahimi S; Lim GJ
    Artif Intell Med; 2021 Nov; 121():102193. PubMed ID: 34763808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic radiotherapy (SBRT) as a sole or salvage therapy in non-small cell lung cancer patients.
    Dworzecki T; Idasiak A; Syguła D; Dworzecka U; Suwiński R
    Neoplasma; 2012; 59(1):114-20. PubMed ID: 22103905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and clinical validation of a robust knowledge-based planning model for stereotactic body radiotherapy treatment of centrally located lung tumors.
    Visak J; McGarry RC; Randall ME; Pokhrel D
    J Appl Clin Med Phys; 2021 Jan; 22(1):146-155. PubMed ID: 33285034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer.
    Wang X; Zamdborg L; Ye H; Grills IS; Yan D
    BMC Cancer; 2018 Oct; 18(1):962. PubMed ID: 30305131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.